1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Automated Endoscope Reprocessors Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Automated Endoscope Reprocessors Market Revenue and Volume, by Product Type
8.1.1. Standalone AER Units
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Integrated AER Systems (with washers/traceability software)
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Accessory Consumables & Add-ons
8.1.3.1. Market Revenue and Volume Forecast
9.1. Automated Endoscope Reprocessors Market Revenue and Volume, by Endoscope Type
9.1.1. Flexible Endoscope Reprocessors
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Rigid Endoscope Reprocessors
9.1.2.1. Market Revenue and Volume Forecast
10.1. Automated Endoscope Reprocessors Market Revenue and Volume, by Reprocessing Cycle
10.1.1. High-Level Disinfection (HLD)
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Low-Level Disinfection
10.1.2.1. Market Revenue and Volume Forecast
11.1. Automated Endoscope Reprocessors Market Revenue and Volume, by Technology/Feature
11.1.1. Automated Disinfection & Wash Cycles
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Traceability & Documentation Software
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Integrated Leak Detection & Safety Systems
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Remote Monitoring & IoT-enabled Features
11.1.4.1. Market Revenue and Volume Forecast
12.1. Automated Endoscope Reprocessors Market Revenue and Volume, by End-User
12.1.1. Hospitals & Surgical Centers
12.1.1.1. Market Revenue and Volume Forecast
12.1.2. Ambulatory Surgical Centers (ASCs)
12.1.2.1. Market Revenue and Volume Forecast
12.1.3. Diagnostic/Endoscopy Centers
12.1.3.1. Market Revenue and Volume Forecast
12.1.4. Others (Clinics, Specialty Practices)
12.1.4.1. Market Revenue and Volume Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product Type
13.1.2. Market Revenue and Volume Forecast, by Endoscope Type
13.1.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.1.4. Market Revenue and Volume Forecast, by Technology/Feature
13.1.5. Market Revenue and Volume Forecast, by End-User
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product Type
13.1.6.2. Market Revenue and Volume Forecast, by Endoscope Type
13.1.6.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.1.6.4. Market Revenue and Volume Forecast, by Technology/Feature
13.1.6.5. Market Revenue and Volume Forecast, by End-User
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product Type
13.1.7.2. Market Revenue and Volume Forecast, by Endoscope Type
13.1.7.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.1.7.4. Market Revenue and Volume Forecast, by Technology/Feature
13.1.7.5. Market Revenue and Volume Forecast, by End-User
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product Type
13.2.2. Market Revenue and Volume Forecast, by Endoscope Type
13.2.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.2.4. Market Revenue and Volume Forecast, by Technology/Feature
13.2.5. Market Revenue and Volume Forecast, by End-User
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product Type
13.2.6.2. Market Revenue and Volume Forecast, by Endoscope Type
13.2.6.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.2.7. Market Revenue and Volume Forecast, by Technology/Feature
13.2.8. Market Revenue and Volume Forecast, by End-User
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product Type
13.2.9.2. Market Revenue and Volume Forecast, by Endoscope Type
13.2.9.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.2.10. Market Revenue and Volume Forecast, by Technology/Feature
13.2.11. Market Revenue and Volume Forecast, by End-User
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product Type
13.2.12.2. Market Revenue and Volume Forecast, by Endoscope Type
13.2.12.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.2.12.4. Market Revenue and Volume Forecast, by Technology/Feature
13.2.13. Market Revenue and Volume Forecast, by End-User
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product Type
13.2.14.2. Market Revenue and Volume Forecast, by Endoscope Type
13.2.14.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.2.14.4. Market Revenue and Volume Forecast, by Technology/Feature
13.2.15. Market Revenue and Volume Forecast, by End-User
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product Type
13.3.2. Market Revenue and Volume Forecast, by Endoscope Type
13.3.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.3.4. Market Revenue and Volume Forecast, by Technology/Feature
13.3.5. Market Revenue and Volume Forecast, by End-User
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product Type
13.3.6.2. Market Revenue and Volume Forecast, by Endoscope Type
13.3.6.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.3.6.4. Market Revenue and Volume Forecast, by Technology/Feature
13.3.7. Market Revenue and Volume Forecast, by End-User
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product Type
13.3.8.2. Market Revenue and Volume Forecast, by Endoscope Type
13.3.8.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.3.8.4. Market Revenue and Volume Forecast, by Technology/Feature
13.3.9. Market Revenue and Volume Forecast, by End-User
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product Type
13.3.10.2. Market Revenue and Volume Forecast, by Endoscope Type
13.3.10.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.3.10.4. Market Revenue and Volume Forecast, by Technology/Feature
13.3.10.5. Market Revenue and Volume Forecast, by End-User
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product Type
13.3.11.2. Market Revenue and Volume Forecast, by Endoscope Type
13.3.11.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.3.11.4. Market Revenue and Volume Forecast, by Technology/Feature
13.3.11.5. Market Revenue and Volume Forecast, by End-User
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product Type
13.4.2. Market Revenue and Volume Forecast, by Endoscope Type
13.4.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.4.4. Market Revenue and Volume Forecast, by Technology/Feature
13.4.5. Market Revenue and Volume Forecast, by End-User
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product Type
13.4.6.2. Market Revenue and Volume Forecast, by Endoscope Type
13.4.6.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.4.6.4. Market Revenue and Volume Forecast, by Technology/Feature
13.4.7. Market Revenue and Volume Forecast, by End-User
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product Type
13.4.8.2. Market Revenue and Volume Forecast, by Endoscope Type
13.4.8.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.4.8.4. Market Revenue and Volume Forecast, by Technology/Feature
13.4.9. Market Revenue and Volume Forecast, by End-User
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product Type
13.4.10.2. Market Revenue and Volume Forecast, by Endoscope Type
13.4.10.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.4.10.4. Market Revenue and Volume Forecast, by Technology/Feature
13.4.10.5. Market Revenue and Volume Forecast, by End-User
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product Type
13.4.11.2. Market Revenue and Volume Forecast, by Endoscope Type
13.4.11.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.4.11.4. Market Revenue and Volume Forecast, by Technology/Feature
13.4.11.5. Market Revenue and Volume Forecast, by End-User
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product Type
13.5.2. Market Revenue and Volume Forecast, by Endoscope Type
13.5.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.5.4. Market Revenue and Volume Forecast, by Technology/Feature
13.5.5. Market Revenue and Volume Forecast, by End-User
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product Type
13.5.6.2. Market Revenue and Volume Forecast, by Endoscope Type
13.5.6.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.5.6.4. Market Revenue and Volume Forecast, by Technology/Feature
13.5.7. Market Revenue and Volume Forecast, by End-User
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product Type
13.5.8.2. Market Revenue and Volume Forecast, by Endoscope Type
13.5.8.3. Market Revenue and Volume Forecast, by Reprocessing Cycle
13.5.8.4. Market Revenue and Volume Forecast, by Technology/Feature
13.5.8.5. Market Revenue and Volume Forecast, by End-User
14.1. STERIS plc
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Olympus Corporation
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Advanced Sterilization Products (ASP) (Fortive Corporation)
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Getinge AB
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Cantel Medical Corp. (now part of STERIS)
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Steelco S.p.A. (Miele Group)
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Wassenburg Medical B.V. (HOYA Corporation)
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Belimed AG (Metall Zug AG)
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Ecolab Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Custom Ultrasonics, Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client